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Abstract
Background: Callistemon citrinus (Curtis.) (Family- Myrtaceae) is a popular evergreen shrub in Bangladesh. In the
present study, the leaves of this plant have been assessed comprehensively for free radical scavenging,
thrombolytic and membrane stabilizing activities.
Methods: The leaves were collected, powdered and extracted with methanol. The extract was then concentrated
and successively fractionated into petroleum ether, carbon tetrachloride, chloroform and aqueous soluble fractions.
The extractives were investigated for free radical scavenging, thrombolytic and membrane stabilizing activities.
Results: In case of 1,1 diphenyl-2-picrylhydrazyl (DPPH) and hydrogen peroxide radical scavenging assays, the crude
methanol extract of the leaves showed the highest free radical scavenging activity among the tested materials
including standard ascorbic acid (p = 0.0000). Besides, this extract was also found significantly rich (p = 0.0000) in
phenolics and flavonoids compared to other organic fractions. In thrombolytic study, the petroleum ether fraction
exhibited significantly stronger thrombolysis (p = 0.024) than other leaf extractives but was weaker than the
standard streptokinase. In membrane stabilizing assay, the activity of chloroform fraction was similar to that of
standard acetylsalicylic acid (p = 1.000) in hypotonic solution induced hemolysis. However, membrane stabilization
activity of this chloroform fraction was found significantly stronger than that of the standard (p = 0.0000) in heat
induced hemolysis.
Conclusion: This study has revealed the medicinal capabilities of different organic fractions of C. citrinus displaying
free radical scavenging, thrombolysis and membrane stabilizing antiinflammatory potentials. Further bioactivity
guided isolation is required to obtain pharmacologically secondary metabolites.
Keywords: Callistemon citrinus, Myrtaceae, Free radical scavenging, Membrane stabilization, Thrombolytic,
Antiinflammatory, Antioxidant, Herbal
Background
Plants are the important sources of various pharmaco-
logically active compounds [1]. Among World Health
Organization (WHO) enlisted 252 basic and essential
drugs, 11 % are solely of plant origin [2]. It has been
assessed that there are more than 250,000 flower plant
species in the world [3]. Exploration of bioactivities of
medicinal plants aids to develop phytotherapeutic agents
[4]. WHO has exclusively acknowledged the significance
of herbal medicine for health care system and pub-
lished many strategies, guidelines and standards for
these botanical medicines [5].
Free radicals produced in living cells might result in
oxidative stress, which might trigger a number of diseases.
Antioxidant emerges as savior from this condition [6].
Besides, some synthetic antioxidants such as butylated
hydroxytoluene and butylated hydroxyanisole have been
reported to be unsafe for human health. Thus, the pursuit
for effective, nontoxic and natural antioxidants has been
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intensified in recent years [7]. Mortality rate from throm-
botic diseases such as myocardial or cerebral infarction is
increasing recently. This situation might become more
challenging in the future due to obesity, diabetes, metabolic
syndromes, etc. [8]. Currently, much effort has been con-
centrated on the discovery of natural products as effective
antithrombotic drugs [9]. Inflammatory processes are
involved with many severe conditions, such as neurodegen-
erative diseases, asthma, chronic inflammatory bowel dis-
eases, rheumatoid arthritis, type 2 diabetes, cancer, etc.
[10]. The currently available antiinflammatory drugs in-
clude nonsteroidal antiinflammatory drugs, glucocorticoids,
immunosuppressant drugs and biologicals. Despite these,
therapy is often hindered by side effects. Thus, the discov-
ery of new antiinflammatory drugs is still a need of the
present time [11].
C. citrinus (Curtis.) belongs to the family Myrtaceae. It
is an evergreen shrub known as Red bottle-brush or
Lemon bottle-brush and available all over Bangladesh.
The flower spikes of bottle-brushes form in spring and
summer and are made up of a number of individual
flowers. This is a woody plant and can be 3 m to 4.6 m
long [12]. This herb is popular as folk medicine to treat
diarrhea, dysentery, rheumatism, cough, bronchitis, etc.
[13, 14]. It has already been reported that this plant has
antimicrobial [15], relaxant [16] and cardioprotective
[17] properties. Previous phytochemical investigations
led to the isolation of various terpenoids, flavonoids, etc.
A herbicidal compound, nitisinone, was also isolated
from this plant [18].
In the present study, the leaves of C. citrinus were
assessed comprehensively for its free radical scavenging,
thrombolytic and membrane stabilizing activities.
Methods
Collection and identification of plant
The leaves of C. citrinus were collected from Dhaka on
August, 2013. The plant was formally identified by an
expert taxonomist at the Bangladesh national herbarium
(BNH), Mirpur Road-1, Dhaka (http://www.bnh.gov.bd).
BNH is a government institute, which provides plant
identification service nationally. For the current experi-
mental plant, an accession number (DACB −38386)
was provided by BNH after identification. The voucher
specimen of the plant has been preserved there for
future reference.
Extraction and fractionation
The collected leaves were dried and powdered. 1 kg of
the powdered materials was soaked separately in 5 L of
methanol at room temperature for 7 days. The extract
was filtered through cotton plug and concentrated with
a rotary evaporator. An aliquot (5 g) of the concentrated
methanol extract was fractionated by modified Kupchan
method [19] to provide petroleum ether, carbon tetra-
chloride, chloroform and aqueous soluble fractions in a
successive manner (Fig. 1). Subsequent evaporation of
solvents yielded petroleum ether (3.22 g), carbon tetra-
chloride (1.12 g), chloroform (0.10 g) and aqueous
(0.25 g) soluble materials, respectively.
Preliminary phytochemical screening
The presence of steroids, quinones, flavonoids and alkaloids
was examined by the reported protocol of Joshi et al., 2013
and Kchaou et al., 2016 [20, 21].
Test for triterpenoids and steroids. 2 mg of extract was
mixed well with 1 ml of acetic anhydride (Merck,
Germany) followed by boiling and cooling. Then, 1 ml
of concentrated sulphuric acid (Merck, Germany) was
added. A brown ring was formed at the junction of two
layers. Formation of green and red color indicated the
presence of steroids and triterpenoids, respectively.
Test for quinones. 2 mg of extract and 2 ml of sodium
hydroxide (0.1 M) (Merck, Germany) were mixed well.
Pink or violet or red color formation indicated the
presence of quinones.
Test for alkaloids. 2 mg of extract was mixed properly
with 0.5 ml of 1 % hydrochloric acid (Merck, Germany)
followed by a few drops of Mayer’s reagent, which was
composed of a aqueous solution of 1.36 (w/v) mercuric
chloride (Sigma-Aldrich, USA) and 5 % (w/v) potassium
iodide (Sigma-Aldrich, USA). The formation of cream or
yellow precipitate indicated the presence of alkaloids.
DPPH free radical scavenging activity
The free radical scavenging activity of the extract was
determined based on the scavenging activity of the stable
Fig. 1 Fractionation. Schematic representation of the modified
Kupchan partitioning of methanolic crude extract of the leaves
of C. citrinus
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1,1 diphenyl-2-picrylhydrazyl (DPPH) free radical [22].
In brief, methanol solutions of the test materials (2 ml)
were prepared at different concentrations and then
mixed well with 3 ml of a DPPH (Sigma-Aldrich, USA)
methanol solution (20 μg/ml). Reaction mixtures were
kept in dark for 20 min at room temperature. Then,
absorbance was determined at 517 nm (UV-1800 UV–
VIS Spectrophotometer, Shimadzu, Japan). Here, ascor-
bic acid was used as standard. The percentage inhibitory
activity (I%) was calculated from,
I% ¼ ð1Asample=AblankÞ  100
Where, Ablank is the absorbance of the control reac-
tion. Extract concentration providing 50 % inhibition
(IC50) was calculated from the graph plotted inhibition
percentage against extract concentration.
Hydrogen peroxide free radical scavenging activity
The free radical scavenging activity was determined
by the scavenging activity of the hydrogen peroxide
free radical [23]. In this study, hydrogen peroxide
(Merck, Germany) of 43 mM was prepared in phos-
phate buffer saline (pH 7.4). Ascorbic acid (standard)
(Sigma-Aldrich, USA) and the extract solution were
prepared separately at concentration from 500 to
15.625 μg/ml. Aliquot of either standard or extract
solution (3.4 ml) was mixed with 0.6 ml of hydrogen
peroxide solution. The reaction mixtures were incu-
bated at room temperature for 10 min and the absorbance
was determined at 230 nm (UV-1800 UV–VIS Spectro-
photometer, Shimadzu, Japan). The percentage inhibitory
activity (I%) was calculated from,
I% ¼ ð1Asample=AblankÞ  100
Where, Ablank is the absorbance of the control. IC50was
calculated from the graph plotted inhibition percentage
against extract concentration.
Total phenolic content determination
Total phenolic content of the extractives was measured
by using Folin-Ciocalteu reagent (Merck, Germany) as
an oxidizing agent and gallic acid (Merck, Germany) as
a standard [24]. In this assay, 0.5 ml of the extract
(2 mg/ml) in water was mixed with 2.5 ml of Folin-
Ciocalteu reagent (10 times diluted with water) and 2 ml
of 7.5 % w/v sodium carbonate (Merck, Germany) solu-
tion and incubated for 20 min in room temperature. The
absorbance was measured at 760 nm using a UV-visible
spectrophotometer (UV-1800 UV–VIS Spectrophotom-
eter, Shimadzu, Japan). Total phenolic content was quanti-
fied by calibration curve obtained from measuring the
known concentrations of gallic acid (0–100 μg/ml). It was
expressed as mg of GAE (gallic acid equivalent)/g of the
dried extract.
Total flavonoid content determination
Total flavonoid content was measured by aluminum
chloride colorimetric assay described earlier by Kchaou
et al., 2016 [21]. 1 ml of 2 % aluminum chloride (Sigma-
Aldrich, USA) solution was added to an aliquot (2 mg/ml
methanol) of extract. The solution was mixed well and in-
cubated for 15 min. The absorbance was measured by
UV-visible spectrophotometer (UV-1800 UV–VIS Spec-
trophotometer, Shimadzu, Japan) against prepared reagent
blank at 430 nm. Total flavonoid content was quantified
by calibration curve obtained from measuring the known
concentrations (0–100 μg/ml of methanol) of quercetin
(Sigma-Aldrich, USA). It was expressed as mg of QE
(quercetin equivalents)/g of the dried extract.
Thrombolytic activity
For in vitro thrombolytic assay [25], 5 ml venous blood
were drawn from healthy volunteers and then dispensed
in pre-weighed sterile microcentrifuge tubes (0.5 ml/
tube). Incubation of them at 37 °C for 45 min allowed
forming clot. The developed serum was removed with-
out disturbing the clot and each tube was again weighed
to measure the clot weight. Leaf extractives (2 mg/
100 μl water) were added in the tubes. 100 μl (equivalent
to 30,000 I.U.) of streptokinase (Altepase®, Beacon phar-
maceuticals Limited, Bangladesh) and 100 μl of distilled
water were used as positive and negative control, re-
spectively. After 90 min incubation of the tubes at 37 °C,
the developed fluid from the clot was discarded very
carefully and tubes were weighed again. Percentage of
lysis of clot was expressed as:
% thrombolysis ¼ ðweight of released clot af ter treatment
=weight of clot bef ore treatmentÞ  100
Membrane stabilizing activity
Hypotonic solution- and heat- induced hemolysis methods
were used for conducting membrane stabilizing assay
[24, 26]. For erythrocyte suspension preparation, 5 ml
of whole blood was collected from healthy human
volunteers in a tube containing dipotassium salt of
EDTA (Merck, Germany) at a concentration 2.2 mg/ml
of blood. It was centrifuged and blood cells were suc-
cessively washed three times with equal volume of
supernatant by isotonic solution (154 mM NaCl) in
10 mM sodium phosphate (Merck, Germany) buffer
(pH 7.4) through centrifugation (10 min at 3000 g).
The cells were resuspended in the same volume of
isotonic buffer solution.
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a) Hypotonic solution-induced hemolysis. 500 μl of
erythrocyte suspension was mixed together with 5 ml
of hypotonic solution (50 mM NaCl) in 10 mM sodium
phosphate buffered saline (pH 7.4) containing the leaf
extractive (2 mg/ml) or reference drug, acetylsalicylic
acid (0.1 mg/ml) (Sigma-Aldrich, USA). The control
sample was consisted of 0.5 ml of erythrocyte mixed
with hypotonic-buffered saline alone. The mixture was
incubated for 10 min at room temperature and centri-
fuged for 10 min at 3000 g. Later, the optical density
(OD) of the supernatant was measured at 540 nm
(UV-1800 UV–VIS Spectrophotometer, Shimadzu,
Japan) for calculating the percentage inhibition of
hemolysis using the following equation-
% Inhibition of hemolysis ¼ fðODcontrol−ODtest samplesÞ
=ODcontrolg  100
b) Heat-induced hemolysis. 5 ml of isotonic buffer
having aliquot of leaf extractive (2 mg/ml) or
reference drug, acetylsalicylic acid (0.1 mg/ml)
(Sigma-Aldrich, USA) was placed into centrifuge
tube. The erythrocyte suspension (30 μl) was then
added to the tube and mixed gently. One set of the
tubes along with control samples were placed in
water bath for incubation at 54 °C for 20 min, while
the other set of the tubes were kept at 0–5 °C in an
ice bath. Later, the reaction mixture was centrifuged
for 3 min at 1300 g and the absorbance of the
supernatant was measured at 540 nm (UV-1800
UV–VIS Spectrophotometer, Shimadzu, Japan). The
percentage inhibition of hemolysis was calculated
according to the equation:
% Inhibition of hemolysis
¼ f1ðODheated test sampleODunheated test sampleÞ
=ðODheated control sampleODheated test sampleÞg  100
Statistical analysis
Three replicates (n = 3) of each sample were used for
statistical analysis and the values are reported as mean
± standard deviation (SD). Data were analyzed by
statistical package for social science (SPSS) software
(Version 20, IBM Corporation, USA) using one-way
ANOVA followed by Tukey’s post hoc test for multiple
comparisons. The values were considered significantly
different at p < 0.05.
Results
Preliminary phytochemical screening
The result of the preliminary phytochemical screening
is shown in Table 1. Steroids and triterpenoids were
abundant in petroleum ether and carbon tetrachloride
fractions. However, quinones were present moderately
in carbon tetrachloride and chloroform fractions. Be-
sides, alkaloids were present in chloroform fraction to
a larger extent.
DPPH free radical scavenging activity
The DPPH free radical scavenging activities are illustrated
in Fig. 2. Here, the DPPH free radical scavenging activity
of the crude methanol extract (IC50 value 1.74 μg/ml) was
significantly stronger (p = 0.0000) than that of the stand-
ard drug, ascorbic acid (IC50 value 5.47 μg/ml).
The order of activity of the extractives might be
mentioned as:
Crude methanol > carbon tetrachloride > aqueous
> petroleum ether > chloroform
Hydrogen peroxide free radical scavenging activity
The hydrogen peroxide free radical scavenging activities
are shown in Fig. 3. Here, the hydrogen peroxide free
radical scavenging activity of the crude methanol extract
(IC50 value 106.03 μg/ml) was significantly stronger (p =
0.047) than that of the standard drug, ascorbic acid (IC50
value 131.04 μg/ml). No significant difference (p = 0.082)
of free radical scavenging activity was seen between the
carbon tetrachloride fraction and ascorbic acid.
The order of activity of the extractives might be
mentioned as:
Crude methanol > carbon tetrachloride > aqueous
> petroleum ether > chloroform
Total phenolic content determination
The phenolic contents of the extractives are shown in
Fig. 4. Among all the extractives, a significantly higher
level (p = 0.0000) of phenolic content was determined
in the crude methanol extract (116.36 mg of GAE/g
of extractive).
Total flavonoid content determination
The flavonoid contents of the extractives are shown in
Fig. 5. The level of flavonoids in crude methanol extract
(45.03 mg of QE/g of extractive) was significantly higher
(p = 0.0000) than other tested extractives.
Thrombolytic activity
The thrombolytic activities of the leaf extractives are
shown in Fig. 6. The highest activity was displayed by
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the petroleum ether fraction (35.95 %), which was
significantly stronger (p = 0.024) than other tested ex-
tractives. However, thrombolytic activity of this fraction
was weaker than that of the standard streptokinase.
Membrane stabilizing activity
The membrane stabilizing activities are displayed in
Fig. 7. In case of hypotonic solution-induced hemolysis
(Fig. 7a), the maximum level of membrane stabilizing
activity (71.84 %) was observed for the chloroform frac-
tion, which was not significantly different (p = 1.000)
from the action of the standard drug, acetylsalicylic acid
(71.98 %). In case of heat-induced hemolysis (Fig. 7b),
the chloroform fraction exhibited highest protection
(46.65 %) to the membrane, which was significantly
stronger (p = 0.0000) than that of the standard drug,
acetylsalicylic acid (42.61 %).
Discussion
Traditional medicine has gained popularity in all regions
of the developing world for meeting some primary
health care needs and is also rapidly spreading in in-
dustrialized countries [27]. WHO has estimated that
25 % of modern medicines are made from plants first
used traditionally [28]. It has been assessed that the
global market for herbal medicines is currently over 60
billion United States dollar annually and growing stead-
ily [29]. Even in the present era of synthetic medicine,
drug discovery research based on herbal medicines is suc-
cessful to a significant extent [3, 30]. With this view, C. citri-
nus, a plant of Bangladesh, has been studied here utilizing
crude methanol extract of leaves and its organic fractions.
Free radicals are produced in human body by various
endogenous systems, exposure to different physiochem-
ical conditions or pathological states [7]. In excess, they
can damage cellular macromolecules including carbohy-
drates, proteins, lipids and nucleic acids. Ultimately, they
promote inflammatory damages, cataract, cancer, aging,
thrombus formation and many other associated prob-
lems [31]. To counteract these disorders, intake of anti-
oxidants are very essential [6]. In DPPH and hydrogen
peroxide free radical scavenging assays, the methanol
extract scavenged free radicals prominently among all
the tested materials including the standard drug, ascor-
bic acid. The carbon tetrachloride fraction also had a
tendency to inhibit free radical production to an extent
in both assays (Figs. 2 and 3).
The analysis of crude methanol extract using UV-visible
spectroscopic technique in the present study demon-
strated the abundance of phenolics and flavonoids than
other extractives (Figs. 4 and 5). Besides, its carbon tetra-
chloride fraction also displayed noticeable level of phen-
olic and flavonoid contents. These findings might partially
explain the reason for stronger free radical scavenging
ability of the crude methanol extract and its carbon tetra-
chloride fraction [32, 33].
Table 1 Preliminary phytochemical screening of different extractives of C. citrinus leaves
Test Crude methanol Petroleum ether Carbon tetrachloride Chloroform Aqueous
Triterpenes ++ +++ +++ + -
Steroids ++ +++ +++ - -
Quinones ++ - ++ ++ +
Alkaloids ++ - ++ +++ +
+++ indicates abundant, ++ indicates moderately present, + indicates trace; − indicates absent
Fig. 2 IC50 values of the standard and extractives of the leaves of C.
citrinus in terms of DPPH free radical scavenging capacity. Bars with
different letters are significantly different (p < 0.05)
Fig. 3 IC50 values of the standard and extractives of the leaves of C.
citrinus in terms of hydrogen peroxide scavenging activity. Bars with
different letters are significantly different (p < 0.05)
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However, thrombosis occurs due to the imbalance be-
tween thrombogenic factors and protective mechanisms,
which leads to many vascular complexities including
stroke, myocardial infarction, deep vein thrombosis,
portal vein thrombosis, renal vein thrombosis, etc. [34].
Tissue plasminogen activator, urokinase, streptokinase,
etc. are used abundantly for treating thrombotic disor-
ders but they are not beyond all limitations. Better
thrombolytic agent is a necessity of time [35, 36]. In this
study, the petroleum ether soluble fraction displayed the
highest thrombolytic activity among the tested extrac-
tives of the leaves (Fig. 6). It has been reported earlier
that terpenoids might have significant potentials of dis-
playing thrombolytic activity [37, 38]. Leaves of C. citri-
nus were reported previously to have some terpenoids
[18]. Besides, a preliminary phytochemical screening of
this study (Table 1) also indicated the presence of abun-
dant terpenoids in petroleum ether fraction. This might
be one of the reasons for exhibiting noticeable thrombo-
lytic activity of the petroleum ether fraction among the
tested extractives.
On the other hand, the membrane stabilization assay
using erythrocytes is used as a common tool to screen
antiinflammatory materials. The erythrocyte membrane
is comparable to the lysosomal membrane and its
stabilization acts as a parameter to indicate the ability of
an extract to stabilize the lysosomal membrane as well
[26]. Maintaining stability of the lysosomal membrane is
vital to limit the inflammatory response by inhibiting the
release of lysosomal constituents of activated neutrophil
such as bactericidal enzymes and proteases, which cause
additional tissue inflammation and damage upon extra-
cellular release [39]. Exposure of erythrocytes to hypo-
tonic medium, heat, methyl salicylate, phenylhydrazine,
etc., results in membrane lysis [40]. In the present study,
Fig. 4 Total phenolic contents of the leaves extractives of C. citrinus.
Bars with different letters are significantly different (p < 0.05)
Fig. 5 Total flavonoid contents of the leaves extractives of C. citrinus.
Bars with different letters are significantly different (p < 0.05)
Fig. 6 Effect of different extractives of leaves of C. citrinus on
thrombolysis. Bars with different letters are significantly
different (p < 0.05)
Fig. 7 Effect of different extractives of C. citrinus on hypotonic
solution induced (a) and heat induced (b) hemolysis of erythrocyte
membrane. Bars with different letters are significantly
different (p < 0.05)
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the chloroform soluble fraction showed the highest mem-
brane stabilizing activity in both heat- and hypotonic solu-
tion induced hemolysis among the plant extractives
(Fig. 7). It was equivalent to the membrane stabilizing
action of the standard drug, acetylsalicylic acid in the
hypotonic solution induced hemolysis assay and more
effective than the standard drug in heat induced hemolysis
assay. Numerous flavonoids and alkaloids have been re-
ported previously to display antiinflammatory activity [41,
42]. Chloroform fraction of the leaves of C. citrinus was
also found to contain flavonoids (Fig. 5) and alkaloids
(Table 1). The persuasive membrane stabilizing antiin-
flammatory activity of this fraction might be related to
these biosynthesized metabolites.
Conclusion
The crude methanol extract of the leaves of C. citrinus
and its different organic fractions displayed different
levels of free radical scavenging, thrombolytic and mem-
brane stabilization activities. In the present study, the
bioactive fractions were identified for particular cases.
The crude methanol extract showed prominent free rad-
ical scavenging activity. On the other hand, the petrol-
eum ether fraction displayed dominant thrombolytic
action. However, the chloroform fraction was very effect-
ive for membrane stabilizing action. Further investiga-
tions are required to isolate bioactive compounds and
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